Wearable Sensors and Mobiles Apps to Monitor Parkinson’s Disease, Essential Tremor, and Other Movement Disorders

  • Wearable sensors
  • Quantitative assessment
  • Mobile apps
  • Web reports and data
  • Remote assessment
  • Clinically validated
  • 21 CFR Part 11 compliant

Kinesia™ products are used as outcome measures in Phase I, II, III, and IV clinical trials.

Kinesia technology is integrated in clinical trials around the globe for Parkinson’s disease, essential tremor, and other movement disorders. Intelligent remote sensing technology increases sensitivity and reliability of outcome measures, improves efficiency with web applications, and expands accessibility.

Clinical Trial Services

  • Protocol Support Integration
  • Site Training
  • Custom Training Materials
  • Custom Site Guides
  • Equipment Shipping Logistics
  • Data Management
  • Kinesia Web Portal Management
  • Cellular Data Management
  • Study Technical Support